AL
VNDA icon

Airain Ltd’s Vanda Pharmaceuticals VNDA Stock Holding History

Airain Ltd’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$170K Sell
10,455
-10,960
-51% -$158K 0.01% 768
2017
Q1 		$300K Buy
21,415
+7,213
+51% +$103K 0.01% 619
2016
Q4 		$227K Buy
+14,202
New +$228K 0.02% 572
2016
Q2 		– Sell
-25,625
Closed -$214K – 915
2016
Q1 		$214K Buy
+25,625
New +$210K 0.01% 663
2015
Q1 		– Sell
-11,626
Closed -$166K – 976
2014
Q4 		$166K Buy
+11,626
New +$138K 0.01% 615

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Airain Ltd's VNDA Position: Q2 2017 in Review

Airain Ltd reduced its Vanda Pharmaceuticals (VNDA) stake by 51% in Q2 2017, selling an estimated $158K and leaving 10,455 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #768.

Airain Ltd first reported a position in VNDA in Q4 2014 and has held it in 5 quarters since. The position peaked at $300K in Q1 2017. 133 funds tracked by Wall St. Rank hold VNDA as of Q2 2017.

  • Airain Ltd held 10,455 shares of Vanda Pharmaceuticals worth $170K as of Q2 2017.
  • Airain Ltd sold 10,960 Vanda Pharmaceuticals shares in Q2 2017, an estimated $158K.
  • Vanda Pharmaceuticals made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #768 holding.
  • Airain Ltd first reported a position in Vanda Pharmaceuticals in Q4 2014 and has held it in 5 quarters since.
  • Airain Ltd's Vanda Pharmaceuticals position peaked at $300K in Q1 2017.
  • 133 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.